Stay updated on CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Sign up to get notified when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.

Latest updates to the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision entry v3.6.6 was added to the Study Record Versions and the previous revision v3.6.5 was removed, updating the record's version history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe revision entry now shows Revision: v3.6.5 as the latest update, replacing the previous v3.6.4. This reflects a small update to the page metadata rather than a substantive change to the study record.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.6.4 was added to the study’s history, while the previous revision v3.6.3 was removed. This reflects an update to the page’s version in the history log.SummaryDifference0.1%

- Check65 days agoChange DetectedA new revision entry (v3.6.3) has been added to the study history, and the previous revision (v3.6.2) has been removed. This represents an update to the record's version history.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.6.2 to the study record history, reflecting a software update to the page's revision tracking. This update marks the latest version label in the history table.SummaryDifference0.1%

- Check87 days agoChange DetectedThe study record now indicates that the trial is no longer looking for participants, signaling that enrollment has been halted. This update also accompanies a revision label of v3.6.0, replacing the prior v3.5.5.SummaryDifference0.7%

Stay in the know with updates to CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.